Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Gliatech licenses ADCON products in Japan

Jan. 14, 1997

Carrington Laboratories enters Middle East and African markets

Jan. 14, 1997

Allergan claims retinoid-like compounds

Jan. 13, 1997

Cariel trial initiated

Jan. 9, 1997

Galderma develops novel compounds active on cell differentiation and proliferation

Jan. 9, 1997

Study results reported for Immune Response antipsoriatic agent

Jan. 8, 1997

Tri-Point seeks FDA approval for TraumaSeal

Jan. 8, 1997

Regranex update

Jan. 7, 1997

Oral contraceptive cleared by FDA as acne treatment

Jan. 7, 1997

Sugen files IND for antipsoriatic agent

Jan. 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...